LKFT:NASDAQ
Lakefront Biotherapeutics NV - ADR
$33.45
arrow_downward
-1.82%(-0.62) 1D
Nov 19, 3:27:17 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LKFT...
Open
$33.70
High
$34.12
Low
$33.32
Mkt. cap
2.27B
Avg. vol.
261.26K
Volume
169.50K
52-wk high
$35.54
52-wk low
$25.68
Beta
0.22
Shares outstanding
65.90M
No. of employees
196
Open
$33.70
High
$34.12
Low
$33.32
Mkt. cap
2.27B
Avg. vol.
261.26K
Volume
169.50K
52-wk high
$35.54
52-wk low
$25.68
Beta
0.22
Shares outstanding
65.90M
No. of employees
196
News stories
From web sources and news partners
GuruFocus
·
3 days ago
LKFT Maintains Equal-Weight Rating by Morgan Stanley -- Price Ta
Profile
Lakefront Biotherapeutics is a Belgian pharmaceutical research company which was founded in 1999. Its headquarters are located in Mechelen and has additional locations in Leiden, Romainville, Basel, Milan, Madrid, Boston and Zagreb.
The company develops drugs against rheumatoid arthritis, Crohn's disease, ulcerative colitis, psoriasis, systemic lupus erythematosus and cystic fibrosis. Wikipedia
About Lakefront Biotherapeutics NV - ADR
CEOPaul Stoffels | Paul Stoffels
Employees196
Founded1999
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitelakefrontbio.com